| Literature DB >> 35558729 |
Matheus Rodrigues de Souza1, Mayra Aparecida Côrtes1, Gustavo Carlos Lucena da Silva1, Davi Jorge Fontoura Solla2,3, Eryanne Garcia Marques1, Wellithon Luz Oliveira Junior1, Caroline Ferreira Fagundes1, Manoel Jacobsen Teixeira2, Robson Luis Oliveira de Amorim2, Andres M Rubiano4, Angelos G Kolias3,5, Wellingson Silva Paiva2,3.
Abstract
The present study aims to evaluate the accuracy of the prognostic discrimination and prediction of the short-term mortality of the Marshall computed tomography (CT) classification and Rotterdam and Helsinki CT scores in a cohort of TBI patients from a low- to middle-income country. This is a post hoc analysis of a previously conducted prospective cohort study conducted in a university-associated, tertiary-level hospital that serves a population of >12 million in Brazil. Marshall CT class, Rotterdam and Helsinki scores, and their components were evaluated in the prediction of 14-day and in-hospital mortality using Nagelkerk's pseudo-R 2 and area under the receiver operating characteristic curve. Multi-variate regression was performed using known outcome predictors (age, Glasgow Coma Scale, pupil response, hypoxia, hypotension, and hemoglobin values) to evaluate the increase in variance explained when adding each of the CT classification systems. Four hundred forty-seven patients were included. Mean age of the patient cohort was 40 (standard deviation, 17.83) years, and 85.5% were male. Marshall CT class was the least accurate model, showing pseudo-R 2 values equal to 0.122 for 14-day mortality and 0.057 for in-hospital mortality, whereas Rotterdam CT scores were 0.245 and 0.194 and Helsinki CT scores were 0.264 and 0.229. The AUC confirms the best prediction of the Rotterdam and Helsinki CT scores regarding the Marshall CT class, which presented greater discriminative ability. When associated with known outcome predictors, Marshall CT class and Rotterdam and Helsinki CT scores showed an increase in the explained variance of 2%, 13.4%, and 21.6%, respectively. In this study, Rotterdam and Helsinki scores were more accurate models in predicting short-term mortality. The study denotes a contribution to the process of external validation of the scores and may collaborate with the best risk stratification for patients with this important pathology. © Matheus Rodrigues de Souza et al., 2022; Published by Mary Ann Liebert, Inc.Entities:
Keywords: CT scoring; prognostic models; traumatic brain injury
Year: 2022 PMID: 35558729 PMCID: PMC9081064 DOI: 10.1089/neur.2021.0067
Source DB: PubMed Journal: Neurotrauma Rep ISSN: 2689-288X
Scoring Systems for the Assessment of CT in Patients with TBI
| CT classification | Classification or component | Description |
|---|---|---|
| Marshall CT classification | Diffuse Injury Grade I | No visible intracranial pathology |
| Diffuse Injury Grade II | Midline shift of 0–5 mm, basal cisterns remain visible, no high- or mixed-density lesions >25 cm3 | |
| Diffuse Injury Grade III | Midline shift of 0–5 mm, basal cisterns compressed or completely effaced, no high- or mixed-density lesions >25 cm3 | |
| Diffuse Injury Grade IV | Midline shift >5 mm, no high- or mixed-density lesions >25 cm3 | |
| Diffuse Injury Grade V + IV | High- or mixed-density lesions >25 cm3 | |
| Rotterdam CT score | Basal cisterns | 0: normal, 1: compressed, 2: absent |
| Midline shift | 0: no shift or ≤5 mm,1: shift >5 mm | |
| Epidural mass lesion | 0: present, 1: absent | |
| Intraventricular hemorrahage or tSAH | 0: present, 1: absent | |
|
|
| |
| Helsinki CT score | Mass lesion type | Subdural hematoma: 2, intracerebral hematoma: 2, epidural hematoma: −3 |
| Mass lesion size | Hematoma volume >25 cm3 | |
| Intraventricular hemorrahage | Present: 3 | |
| Suprasellar cisterns | Normal: 0, compressed: 1, absent: 5 | |
|
|
|
CT, computerized tomography; TBI, traumatic brain injury; tSAH, traumatic subarachnoid hemorrhage.
Patient Characteristics for 14-Day Mortality Outcome
| Variable | No. of patients (%) | Alive | Death | |
|---|---|---|---|---|
| Age, years | <0.001 | |||
| >18 | 16 (3.6) | 10 (03.4) | 06 (4) | |
| 18–29 | 120 (26.8) | 102 (34.5) | 18 (11.9) | |
| 30–39 | 103 (23) | 73 (24.7) | 30 (19.9) | |
| 40–49 | 75 (16.8) | 48 (16.2) | 27 (17.9) | |
| <50 | 133 (29.8) | 63 (21.3) | 70 (46.4) | |
| Sex | 0.003 | |||
| Male | 382 (85.5) | 260 (87.8) | 122 (80.8) | |
| Female | 65 (14.5) | 36 (12.2) | 29 (19.2) | |
| TBI class | 0.002 | |||
| Mild: GCS 13–15 | 96 (21.5) | 80 (27) | 16 (10.6) | |
| Moderate: GCS 9–12 | 64 (14.3) | 46 (15.5) | 18 (11.9) | |
| Severe: GSC 3–8 | 287 (64.2) | 170 (57.4) | 117 (77.5) | |
| Mechanism of injury | <0.001 | |||
| RTI | 262 (58.6) | 184 (62.2) | 78 (51.7) | |
| Fall | 136 (30.4) | 77 (26.0) | 59 (39.1) | |
| Other | 49 (11) | 35 (11.8) | 14 (9.3) | |
| Pupil responsiveness | <0.001 | |||
| Responsive | 365 (81.7) | 272 (91.9) | 93 (61.6) | |
| Unilateral unresponsive | 56 (12.5) | 20 (6.8) | 36 (23.8) | |
| Bilateral unresponsive | 26 (5.8) | 04 (1.4) | 22 (14.6) | |
| Marshall CT class | <0.001 | |||
| Diffuse Injury I | 18 (4.0) | 13 (4.4) | 05 (3.3) | |
| Diffuse Injury II | 193 (43.2) | 119 (40.2) | 74 (49) | |
| Diffuse Injury III | 37 (8.3) | 22 (7.4) | 15 (9.9) | |
| Diffuse Injury IV | 20 (4.5) | 13 (4.4) | 07 (4.6) | |
| Diffuse Injury V | 175 (39.1) | 127 (42.9) | 48 (31.8) | |
| Diffuse Injury VI | 04 (0.9) | 02 (0.7) | 02 (1.3) | |
| Rotterdam CT score[ | <0.001 | |||
| 1 | 09 (2) | 09 (100) | — | |
| 2 | 68 (15.2) | 64 (18.6) | 04 (3.9) | |
| 3 | 205 (45.9) | 181 (52.2) | 24 (23.5) | |
| 4 | 63 (14.1) | 50 (11.6) | 24 (23.5) | |
| 5 | 57 (12.8) | 31 (9) | 26 (25.5 | |
| 6 | 45 (10.1) | 20 (5.8) | 25 (24.5) | |
| Helsinki CT score[ | <0.001 | |||
| 03 (0/5) | 02 (0/4) | 05 (3/9) | ||
| Hypoxia | 0.002 | |||
| Present | 52 (11.6) | 33 (9.6) | 19 (18.6) | |
| Missing | 192 (43) | 161 (46.7) | 31 (30.4) | |
| Unknown | 203 (45.4) | 151 (43.8) | 52 (51) | |
| Hypotension | 0.001 | |||
| Present | 54 (12.1) | 32 (9.3) | 22 (21.6) | |
| Missing | 350 (78.3) | 281 (81.4) | 69 (67.6) | |
| Unknown | 43 (9.6) | 32 (9.3) | 11 (10.8) | |
| Hemglobin (g/dL)[ | 0.088 | |||
| 11.6 (10/13) | 11.8 (10.17/13.12) | 11.2 (9.95/12.45) | ||
| 14-day mortality |
| 345 (77.2) | 102 (22.8) | — |
| In-hospital mortality |
| 151 (33.8) | 151 (33.8) | — |
Median (interquartile range). All other variables: number (%).
GCS, Glasgow Coma Scale; MOI, mechanism of injury; RTI, road traffic injury.
Variation Explained, Discriminative Ability, and Calibration of All Scores for Predicting Outcome in TBI
| Pseudo- | AUC (95% CI) | Brier Score | |
|---|---|---|---|
| 14-day mortality | |||
| Marshall CT class | 0.122 | 0.610 (0.553–0.668) | 0.172 |
| Rotterdam CT score | 0.245 | 0.762 (0.709–0.815) | 0.147 |
| Helsinki CT score | 0.264 | 0.752 (0.698–0.807) | 0.149 |
| In-hospital mortality | |||
| Marshall CT class | 0.057 | 0.575 (0.520–0.629) | 0.183 |
| Rotterdam CT score | 0.194 | 0.712 (0.659–0.764) | 0.158 |
| Helsinki CT score | 0.229 | 0.716 (0.664–0.767) | 0.161 |
TBI, traumatic brain injury; CT, computerized tomography; AUC, area under the curve; CI, confidence interval.
FIG. 1.Receiver operating characteristic curves for prediction of (A) 14-day mortality and (B) in-hospital mortality. AUC, area under the receiver operating characteristic curve.
CT Models in Multi-Variable Analysis Together with Available IMPACT Variables
| Model | Omnibus test | Nagelkerke's Pseudo- | AUC (CI 95%) | Brier Score |
|---|---|---|---|---|
| Base model | — | 0.354 | 0.802 (0.723–0.882) | 0.121 |
| Base model + Marshall CT | 0.038 | 0.376 | 0.812 (0.735–0.890) | 0.120 |
| Base model + Rotterdam CT | <0.001 | 0.492 | 0.880 (0.818–0.941) | 0.114 |
| Base model + Helsinki CT | <0.001 | 0.570 | 0.898 (0.844–0.953) | 0.117 |
The base model consists of: age, better motor response on the Glasgow Coma Scale, pupillary response, hypoxia, and hypotension and hemoglobin levels. The Omnibus test p values describe whether the included score significantly added independent information to the standard model.
CT, computerized tomography; IMPACT, International Mission for Prognosis and Clinical Trials in TBI; AUC, area under the curve; CI, confidence interval.